 |
 |
High productivity using a three-shift-basis operation (24 hr staffing) at all manufacturing sites |
|
 |
 |
Manufacturing combination for biotechnology and synthetic technology |
|
|
 |
Continual expansion and improvement for more effective production |
|
|
 |
Ready to accommodate for better capacities reflecting customer demands |
|
|
|
 |
 |
 |
 |
|
Takasago Plant (Japan) |
|
Kaneka Singapore |
|
 |
Biotechnology |
Synthetic Technology |
Facility
Size |
Pilot |
○ |
○ |
| Semi-commercial |
○ |
○ |
| Commercial |
○ |
○ |
| Plants for API’s |
○ |
○ |
| Single Reactor Volume |
up to 100,000’s liters
|
up to 10,000 liters
* Glass-lined reactors
* Stainless steel reactors |
| Features |
* Immobilized microbe/enzyme
* Segregation of recombinant microbes pursuant to regulation for manufacturing technology of recombinant DNA. |
* Effective connection with biotechnology plants |
|
|